Mortality risk among new onset injection drug users

Addiction. 2004 Aug;99(8):946-54. doi: 10.1111/j.1360-0443.2004.00780.x.

Abstract

Aims: To characterize mortality experience among those who only recently started injection.

Design: Prospective study.

Setting: Independent study clinic within high drug use neighborhoods.

Participants: In 1988-1989, we enrolled 256 adult injection drug users (IDUs) recruited through street outreach who had initiated injection within the prior 2 years.

Measurements: Consenting participants underwent venipuncture for HIV antibody testing and interviews. We prospectively ascertained date and cause of death through follow-up contact and registry linkages. Analyses included standardized mortality ratios (SMRs) with local, state and national mortality data, adjusted for age, gender and race.

Findings: Baseline median age was 30 years, 70% were male, 95% were African-American and 90% injected within the prior 6 months. We identified 69 deaths through October 2000; mortality rate was 3.3/100 person-years. The adjusted SMR with the USA (and Baltimore) as the reference for IDUs was 4.40 (2.43) for 1991-1992, which increased to 8.12 (4.13) by 1993-1994, decreased to 4.43 (2.13) by 1997-1998 and increased slightly to 5.35 (2.79) during 1999-2000. Excluding HIV-related mortality, SMRs remained elevated. Decline in SMRs was not linked to drug abuse treatment.

Conclusions: These data demonstrate excess mortality among new-onset IDUs compared with demographically similar peers in the general population, indicating the need for interventions to prevent premature death among young IDUs.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Aged
  • Cause of Death
  • Cohort Studies
  • Female
  • HIV Infections / mortality
  • Humans
  • Incidence
  • Longitudinal Studies
  • Male
  • Middle Aged
  • Poisson Distribution
  • Prospective Studies
  • Substance Abuse, Intravenous / mortality*